Home / About Us / SID&T Advisory Board

SID&T Advisory Board

Science in Donation & Transplant (SID&T), a leading national advocacy and policy group dedicated to scientific research and innovation in organ donation and transplantation oversight and governance, has announced the creation of a new Advisory Board and the appointment of initial members. The SID&T Advisory Board is intended to provide counsel and guidance on donation and transplantation performance measurement, policy development, and messaging to ensure public trust essential to organ donation. The advisory board members bring experience in clinical transplantation, transplant and donation ethics, governmental oversight, and public policy to SID&T.

The advisory board members bring experience in clinical transplantation, transplant and donation ethics, governmental oversight, and public policy to SID&T.

Read the Press Release Announcing the Advisory Board

Read the press release →

SID&T Advisory Board

  • Anthony Watkins, MD

    The Surgical Director of the Center for Kidney and Pancreas Transplant Program at Tampa General Hospital. Prior, Dr. Watkins was an attending transplant surgeon and clinical assistant professor of surgery at NYU Langone Health.

  • Matthew Cooper, MD

    Chief of Transplantation, Director of Solid Organ Transplant and a Professor of Surgery at the Medical College of Wisconsin and Mark B. Adams Distinguished Professor of Surgery.

  • Brendan Parent, JD

    Director of transplant ethics and policy research, and assistant professor of bioethics in the division of medical ethics and surgery at NYU Grossman School of Medicine.

  • Anne Murphy, MBA FACHE

    Consultant and former Chief Administrative Officer, Department of Learning Health Sciences University of Michigan Medical School, and Transplant Center Administrative Director – University of Michigan Hospitals and Health Centers.

  • J. Thomas Rosenthal, MD

    Retired Chief Medical Officer, UCLA Medical Center, Associate Vice Chancellor, David Geffen School of Medicine at UCLA, Director of the Kidney Transplant Program at UCLA.

  • Herb Conaway, MD, JD

    New Jersey Assemblyman, Chair Health Committee; US Congressional Candidate, Captain, US Air Force Physician, Director of Health, Burlington County.

  • "It is now well understood, based on abundant scientific evidence, that the methodology in the 2020 OPO rule is fatally flawed and that CMS is going to have to revise the rule. The whole OPO accreditation process needs to be modernized in accordance with long-standing and well-established principles of measurement for quality and accreditation and as proposed in the National Academies of Science, Engineering and Medicine landmark 2022 study Realizing the Promise of Equity in the Organ Transplantation System.”

    – J. Thomas Rosenthal, MD

  • "The best governing hears from all sides, is thoroughly vetted and follows the science. We need to bring expertise and commonsense judgement to produce the best policy.”

    – Herb Conaway, MD, JD, veteran legislator

  • "The U.S. Organ Donation and Transplantation system is renowned as the world’s most advanced and accomplished. We must insist that changes and improvements to this system be driven from evidencebased practice and scientific study, rather than various looming and, sometimes, competing forms of selfinterest. We owe this to the patients and families we serve, whose lives and wellbeing hang in the balance."

    – Anne Murphy, MBA FACHE

  • "By fostering partnerships across clinical, scientific, and policy domains, we can drive necessary improvements that are both innovative and inclusive, ensuring every patient has the chance for a life-saving transplant."

    – Anthony Watkins, MD